Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Other Non-Current Liabilities (2020 - 2021)

Rani Therapeutics Holdings' Other Non-Current Liabilities history spans 2 years, with the latest figure at $606000.0 for Q2 2021.

  • On a quarterly basis, Other Non-Current Liabilities changed N/A to $606000.0 in Q2 2021 year-over-year; TTM through Jun 2021 was $606000.0, a N/A change, with the full-year FY2020 number at $320000.0, changed N/A from a year prior.
  • Other Non-Current Liabilities came in at $606000.0 for Q2 2021, up from $320000.0 in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $606000.0 in Q2 2021, with the low at $320000.0 in Q4 2020.